CKD Bio Corp.
Develops APIs, intermediates, and probiotics using fermentation and synthesis.
063160 | KO
Overview
Corporate Details
- ISIN(s):
- KR7063160006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서대문구 충정로 8, 서울특별시
- Website:
- https://www.ckdbio.com/en/home
- Sector:
- Manufacturing
Description
CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
투자판단관련주요경영사항
|
Korean | 7.4 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 912.4 KB | ||
| 2025-07-25 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.2 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | 968.8 KB | ||
| 2025-04-25 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.2 KB | ||
| 2025-04-09 00:00 |
투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청)
|
Korean | 14.0 KB | ||
| 2025-04-01 00:00 |
투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인)
|
Korean | 7.5 KB | ||
| 2025-03-26 00:00 |
정기주주총회결과
|
Korean | 18.6 KB | ||
| 2025-03-18 00:00 |
감사보고서제출
|
Korean | 11.3 KB | ||
| 2025-03-18 00:00 |
사업보고서 (2024.12)
|
Korean | 1.3 MB | ||
| 2025-02-25 00:00 |
주주총회소집결의
|
Korean | 7.1 KB | ||
| 2025-02-25 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.8 KB | ||
| 2025-02-25 00:00 |
주주총회소집공고
|
Korean | 111.3 KB | ||
| 2025-02-25 00:00 |
의결권대리행사권유참고서류
|
Korean | 89.4 KB | ||
| 2025-01-24 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 11.8 KB |
Automate Your Workflow. Get a real-time feed of all CKD Bio Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CKD Bio Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CKD Bio Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
